Prudential Financial Inc Geron Corp Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

A detailed history of Prudential Financial Inc transactions in Geron Corp stock. As of the latest transaction made, Prudential Financial Inc holds 44,132 shares of GERN stock, worth $163,729. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,132

Previous 44,352 0.5%

Holding current value

$163,729

Previous $188,000 6.38%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$4.17 - $4.99 $917 - $1,097	-220 Reduced 0.5%	44,132 $200,000
Q2 2024 Aug 13, 2024	BUY	$3.1 - $5.09 $23,358 - $38,353	7,535 Added 20.47%	44,352 $188,000
Q4 2023 Feb 13, 2024	BUY	$1.74 - $2.31 $2,818 - $3,742	1,620 Added 4.6%	36,817 $77,000
Q3 2023 Nov 13, 2023	SELL	$2.11 - $3.28 $315,023 - $489,703	-149,300 Reduced 80.92%	35,197 $74,000
Q2 2023 Aug 11, 2023	BUY	$1.97 - $3.69 $9,249 - $17,324	4,695 Added 2.61%	184,497 $592,000
Q1 2023 May 12, 2023	SELL	$2.14 - $3.4 $103,875 - $165,036	-48,540 Reduced 21.26%	179,802 $390,000
Q4 2022 Feb 14, 2023	SELL	$2.03 - $2.42 $732,342 - $873,039	-360,760 Reduced 61.24%	228,342 $0
Q3 2022 Nov 04, 2022	BUY	$1.67 - $2.94 $224,230 - $394,753	134,270 Added 29.52%	589,102 $1.38 Million
Q2 2022 Aug 15, 2022	BUY	$1.19 - $1.65 $516,341 - $715,935	433,900 Added 2072.9%	454,832 $705,000
Q4 2021 Feb 14, 2022	SELL	$1.22 - $1.72 $2,098 - $2,958	-1,720 Reduced 7.59%	20,932 $26,000
Q3 2021 Nov 15, 2021	BUY	$1.2 - $1.5 $2,460 - $3,075	2,050 Added 9.95%	22,652 $31,000
Q2 2021 Aug 16, 2021	BUY	$1.25 - $1.83 $937 - $1,372	750 Added 3.78%	20,602 $29,000
Q1 2021 May 12, 2021	BUY	$1.52 - $2.1 $608 - $840	400 Added 2.06%	19,852 $31,000
Q4 2020 Feb 16, 2021	BUY	$1.55 - $2.05 $85 - $112	55 Added 0.28%	19,452 $31,000
Q3 2020 Nov 16, 2020	BUY	$1.59 - $2.19 $7,298 - $10,052	4,590 Added 31.0%	19,397 $34,000
Q1 2020 May 12, 2020	SELL	$0.89 - $1.49 $7,841 - $13,128	-8,811 Reduced 37.31%	14,807 $17,000
Q4 2019 Feb 11, 2020	BUY	$1.27 - $1.54 $12,104 - $14,677	9,531 Added 67.66%	23,618 $32,000
Q3 2019 Nov 13, 2019	SELL	$1.15 - $1.59 $15,426 - $21,328	-13,414 Reduced 48.78%	14,087 $18,000
Q2 2019 Aug 08, 2019	BUY	$1.37 - $2.02 $753 - $1,111	550 Added 2.04%	27,501 $0
Q1 2019 May 15, 2019	BUY	$1.01 - $1.83 $11,629 - $21,070	11,514 Added 74.59%	26,951 $0
Q4 2018 Feb 07, 2019	SELL	$0.98 - $1.85 $539 - $1,017	-550 Reduced 3.44%	15,437 $15,000
Q3 2018 Nov 07, 2018	BUY	$1.76 - $6.38 $2,182 - $7,911	1,240 Added 8.41%	15,987 $0
Q2 2018 Aug 13, 2018	BUY	$3.29 - $4.82 $1,513 - $2,217	460 Added 3.22%	14,747 $0
Q1 2018 May 04, 2018	BUY	$1.81 - $5.98 $724 - $2,392	400 Added 2.88%	14,287 $0
Q3 2017 Nov 02, 2017	BUY	$1.99 - $2.65 $27,635 - $36,800	13,887	13,887 $30,000

Others Institutions Holding GERN

# of Institutions

273

Shares Held

491M

Call Options Held

1.62M

Put Options Held

670K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.4B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Geron Corp Transaction History